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Predicting iliac limb occlusions after bifurcated aortic
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Objective: Graft limb occlusion may complicate endovascular abdominal aortic aneurysm repair. The precise etiologic
factors that contribute to the development of these graft limb thromboses have not been defined. We evaluated our
experience with bifurcated aortic endografts to determine factors that may predict subsequent limb thrombosis. The
management of the thrombosed limbs and the results after treatment were also investigated.
Methods: During a 4-year period, 351 patients with aortic aneurysms underwent treatment with bifurcated endografts
(702 graft limbs at risk). These 351 bifurcated devices included AneuRx (Medtronic, Minneapolis, Minn; n  35),
Ancure (Guidant, Menlo Park, Calif; n  8), Gore (W.L. Gore & Associates, Sunnyvale, Calif; n  25), Talent (World
Medical, Sunrise, Fla; n  255), Teramed (Teramed, Minneapolis, Minn; n  10), and Vanguard (Boston Scientific
Vascular, Natick, Mass; n  18). Details regarding the type of device, mechanism of deployment, and aortoiliac artery
anatomy were collected prospectively and analyzed. Graft limbs were analyzed for diameter, use of additional endograft
iliac extensions, deployment in the external iliac artery, and endograft to vessel oversizing. Follow-up included physical
examination, duplex ultrasonography, and spiral computed tomographic scans at 1 month, 6 months, and 12 months and
annually thereafter. The follow-up period ranged from 2 to 54 months, with a mean follow-up period of 20 months.
Results: Twenty-six of 702 limbs (3.7%) had an occlusion develop. The risk of limb thrombosis was associated with a
smaller limb diameter. Mean graft limb diameter was 14 mm in the occluded population, and patent limbs had a mean
diameter of 16 mm. Thrombosis occurred in 16 of 291 limbs (5.5%) that were 14 mm or less and in 10 of 411 limbs
(2.4%) that were greater than 14 mm (P  .03). Extension of a graft to the external iliac artery was performed in 96 of
the 702 limbs. Eight of these 96 limbs (8.3%) had thrombosis develop as compared with 18 of 606 (3.0%) that extended
to the common iliac artery (P  .01). No significant association was present between limb thrombosis and the
contralateral or ipsilateral side of a device, the configuration of the iliac graft limb end (closed web, open web, or bare
spring), or the degree of iliac graft limb oversizing. AneuRx, Ancure, Vanguard, and Talent grafts each sustained limb
occlusions, with no occlusions seen among the Gore and Teramed devices. No significant increased risk of graft limb
thrombosis was observed in unsupported grafts (1/16; 6.3%) versus supported grafts (25/686; 3.6%; P  not
significant). Thromboses occurred between 1 day and 23 months after surgery. Thirteen of the 26 thromboses (50%)
occurred within 30 days of surgery. Presenting symptoms were mild to moderate claudication in eight patients (30.8%),
severe claudication in 16 patient (61.5%), and paresthesia and rest pain in two patients (7.7%). Eighteen of 26 patients
(69.2%) eventually needed intervention to reestablish flow to the occluded limb, including thrombolysis and stenting in
two patients (7.7%), axillary femoral bypass in one patient (3.8%), femoral-femoral bypass in 13 patients (50.0%), and
axillary-bifemoral bypass in two patients (7.7%). All patients with mild to moderate symptoms under observation had
improvement in symptoms with no further interventions necessary. All revascularizations were successful in relieving
symptoms.
Conclusion: Graft limb occlusion is a recognized complication of endovascular treatment of abdominal aortic aneurysms
that may be associated with smaller graft limb diameter and extension to the external iliac artery. Occlusions usually
necessitate additional intervention for resolution of ischemic symptoms. The use of small diameter grafts should be
avoided when possible to reduce the risk of graft limb occlusions. (J Vasc Surg 2002;36:679-84.)
Aortic endograft limb thrombosis is a known compli-
cation after endovascular repair of infrarenal abdominal
aortic aneurysms.1-9 After limb thrombosis, symptoms may
necessitate additional interventions, including endovascu-
lar and direct surgical revascularization.10-12 These inter-
ventions have associated morbidity and often necessitate
rehospitalization. This study analyzed the factors associated
with bifurcated endovascular graft limb thrombosis and
assessed the treatment and outcome during a 4-year period.
PATIENTS AND METHODS
From July 1997 to December 2001, 351 patients with
infrarenal aortic aneurysms underwent treatment with bi-
furcated endografts at the Mount Sinai Medical Center,
yielding a population of 702 limbs at risk for thrombosis.
All data regarding each procedure were entered prospec-
tively into a vascular registry. All procedures were per-
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formed with protocol approved by the institutional review
board. Specific factors analyzed were graft limb diameter,
iliac artery diameter, graft to vessel oversizing, deployment
to the external iliac artery, identification of contralateral or
ipsilateral limb, device type, and support. Devices used
were AneuRx (Medtronic, Minneapolis, Minn; n  35),
Ancure (Guidant, Menlo Park, Calif; n  8), Excluder
(W.L. Gore & Associates, Sunnyvale, Calif; n 25), Talent
(World Medical, Sunrise, Fla; n  255), Ariba (Teramed,
Minneapolis, Minn; n  10), and Vanguard (Boston Sci-
entific Vascular, Natick, Mass; n  18).
The follow-up period ranged from 2 to 54 months
(mean, 20 9 months). History and physical examination,
radiograph, duplex scan, and 3-mm slice computed tomo-
graphic scan with intravenous contrast were performed at 1
month, 3 months, 6 months, and 12 months after surgery
and annually thereafter. Limb occlusions were identified at
office visit follow-up and at emergency department visits
when symptoms were acute. Computed tomographic scan
confirmed graft limb thrombosis in all 26 cases, duplex
ultrasound scan in six cases, and angiography in two cases.
Statistical analysis was performed with regression analysis.
RESULTS
Thrombosis occurred in 26 of the 702 limbs at risk
(3.7%). Investigation of factors that potentially predisposed
to limb thrombosis identified a significant association be-
tween the mean limb diameter and the occurrence of a limb
thrombosis (Table I). Although the endografts limbs used
during the study period included diameters that ranged
from 8 to 24 mm, the population of occluded limbs had a
significantly smaller mean diameter. Occluded limbs
ranged in size from 12 to 20 mm. Among the total popu-
lation of limbs, 41.5% had diameters of 14 mm or less and
91.7% had limb diameters of 16 mm or less. With a thresh-
old limb diameter of 14 mm or less, thrombosis was signif-
icantly more common in limbs 14 mm or less (16/291
limbs; 5.5%) than in limbs greater than 14 mm (10/411
limbs; 2.4%; P .03). Included in the investigation was the
degree of graft oversizing of the vessel. No significant
difference was seen in degree of oversizing between the
population of occluded limbs and the patent limbs (mean,
1.42  0.8 mm oversizing versus 1.49  0.9 mm oversiz-
ing; P not significant). Six of 144 limbs without oversiz-
ing (4.5%) resulted in thrombosis, and 20 of 558 oversized
limbs (3.6%) resulted in thrombosis, confirming no associ-
ation with limited oversizing.
Graft limbs occluded more frequently when extended
to the external iliac artery. Extension of a graft to the
external iliac artery was performed in 96 of the 702 limbs.
Eight of these 96 limbs (8.3%) had thrombosis develop as
compared with 18 of 606 (2.9%) that extended to the
common iliac artery (P  .01). In modular grafts, limb
occlusion was not increased in the contralateral iliac mod-
ular limb as compared with the ipsilateral limb that origi-
nated from the main body of the device. In addition, the
use of additional iliac extensions had no association with
limb thrombosis. Rates of limb occlusion were identified
for each design (Table II). Investigation into the type of
device failed to reveal an association between the unsup-
ported devices and the development of limb occlusion.
Limb thrombosis was observed in one of 16 unsupported
grafts (6.3%) versus 25 of 686 supported grafts (3.6%; P 
not significant; Table III). Although a minority of the
patient population had endoluminal or extraluminal acces-
sory conduits to allow endograft insertion, no limb occlu-
sions occurred within this population of patients.
Thirteen of the 26 limb occlusions (50%) were identi-
fied within 30 days after the aneurysm repair (Table IV).
Nearly all 24 of 26 (92.3%) occurred within the first year of
follow-up. The mean time to occlusion was 5.2  6.5
months, with a range from 1 day to 23 months. Patients
with occluded graft limbs had symptoms that ranged from
mild claudication to rest pain with paresthesia. Presenting
symptoms were mild to moderate claudication in eight
patients (30.8%), severe claudication in 16 patients
(61.5%), and paresthesia and rest pain in two patients
(7.7%). No loss of motor function was found in any pa-
Table II. Rate of limb occlusion among devices
Device
Total limbs
(n  702)
Occluded limbs
(n  26)
AneuRx 70 1 (1.4%)
Ancure 16 1 (6.3%)
Gore 50 0
Talent 510 20 (3.9%)
Teramed 20 0
Vanguard 36 4 (11.1%)
Table III. Rate of limb occlusion in supported versus
unsupported devices
Device limbs Total limbs Occluded limbs
Supported 686 25 (3.6%)
Unsupported 16 1 (6.3%)
Table I. Factors investigated for association with graft limb thrombosis
Limb status
(no.)
Limb diameter
(mean; mm)
Extension to
external iliac
Additional
extension
Device oversizing
(mean; mm)
Patent (676) 15.8  3.4 13.1% (88/676) 25.4% (172/676) 1.49  0.9
Occluded (26) 14.3  2.2 30.8% (8/26) 19.2% (5/26) 1.42  0.8
P value .02 .01 .5 .07
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tients. The patients with more severe symptoms (18/26)
were seen at the emergency department. Physical examina-
tion identified the loss of the femoral pulse in all the
patients with thromboses.
The severity of the symptoms determined the need and
timing of intervention. Although nearly a third of the
patients were observed for minor symptoms, 69.2% of
patients needed a subsequent procedure to reestablish flow
to the affected lower extremity. In the eight patients with
limb thrombosis and extension of the graft to the external
iliac artery, all eight (100%) had symptoms develop that
necessitated intervention, and only 10 of the 18 limbs
(55.6%) with distal implantation in the common iliac artery
that had thromboses develop needed intervention (P 
.03). Interventions included thrombolysis and stenting in
two patients (7.7%), axillary femoral bypass in one patient
(3.8%), femoral-femoral bypass in 13 patients (50%), and
axillary-bifemoral bypass in two patients (7.7%; Table V).
After intervention, all patients had resolution of symptoms
with no permanent sequelae.
DISCUSSION
Endograft limb thrombosis after endovascular repair of
infrarenal abdominal aortic aneurysm is a recognized com-
plication.1-9 Factors that have been proposed to potentially
predispose to limb thrombosis have included areas of ste-
nosis, such as the aortic bifurcation and occlusive or tortu-
ous iliac arteries,4,7,13 unsupported endograft devices,1 ir-
regularity of the endograft lumen from device overlap,14
stent graft material, and changes in forces, such as extrinsic
compression from thrombus and changes in radial force
from increasing luminal blood flow.15,16
A recognized factor in the risk of graft thromboses is
arterial outflow. A limitation in our investigation was the
absence of a quantification of arterial outflow in the form of
pulse volume recording/arterial brachial index. Although
all patients underwent pulse examination before and after
surgery, pulse volume recordings were performed only as
indicated by protocol by device or with concern for change
in pulse examination.
We identified a tendency for endograft limb thrombosis
when the limb diameter was small and extended to the
external iliac artery. We believe this was likely from the
transition that occurred after the bifurcation of the com-
mon iliac artery. The path of the vessel was tortuous in the
transition from the pelvis toward the groin. Deployment of
the device in this location therefore not only resulted in the
diminution in size but also an angulation and potential kink
in the graft. We can speculate that extension of the en-
dograft limb to the external iliac artery will sacrifice hypo-
gastric artery outflow and prove detrimental to graft limb
patency.
One would not expect a diameter of 14 mm to be
problematic in terms of limb thrombosis. More likely is that
underlying arterial disease is the responsible element and
the impact of occlusive disease or tortuosity may be more
hemodynamically restrictive to flow. Arterial disease may
result in graft limb diameters that are significantly more
narrowed when compared with device limbs before inser-
tion. With the exclusion of aneurysmal arteries, which were
bridged and not used as fixation sites, the arterial mean
diameters in this population were 14 mm for common iliac
arteries and 11 mm for external iliac arteries. These mea-
surements were taken from preoperative angiograms and
computed tomographic scans that may have limited iden-
tification of more stenotic segments. Intravascular ultra-
sound scan would probably be more beneficial in identifi-
cation of flow restricting lesions and thus arteries at
increased risk for thrombosis.
Although our data fail to reveal any significant associa-
tion between unsupported devices and limb thrombosis,
evidence does exist that lack of device support predisposes
to angulation and kinking with resulting stenosis and
thrombosis of the graft.1 Baum and colleagues1 carried out
an investigation of rates of limb kinking in supported and
unsupported aortic stent grafts. They identified kinking in
18 of 149 limbs (12%). Limb kinking was significantly more
likely in the unsupported groups as opposed to the sup-
ported groups. They identified a 5% rate of kinking neces-
sitating intervention in the supported endografts and a rate
of 44% in the unsupported grafts. Likewise, the rate of
thrombosis was more evident in the unsupported group.
Interestingly, not all grafts are supported in a similar fash-
ion. In the Talent device, limb support in the form of a
longitudinal bar may restrict kinking if the bar lies on the
greater curvature of a bending limb; however, angulation of
the same degree with the support bar on the lesser curva-
ture may result in a kink (Fig 1). The devices used in our
study were predominantly of the supported structures, with
only the Ancure endograft being of the unsupported vari-
ety. We did not find the unsupported graft more likely to
result in thromboses; however, because Ancure accounted
for only 16 of the 702 limbs in the study, a more significant
association may be revealed when a larger proportion of the
data is available from the unsupported variety of grafts.
Table IV. Interval to occlusion after infrarenal aortic
endografting
Occluded limbs
Time interval to occlusion
(mo)
13 (50%) 1
11 (41.7%) 2-12
2 (8.3%) 13-24
Table V. Management of aortic endograft limb
occlusion
Occluded limbs Treatment
2 (7.7%) Thrombolysis and stent
1 (3.8%) Axillary-femoral bypass
13 (50%) Femoral-femoral bypass
2 (7.7%) Axillary-bifemoral bypass
8 (30.8%) Observation
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When an endograft limb diameter exceeds the native
vessel diameter, a degree of graft infolding may be found,
which has been identified as a potential site of decreased
flow.2 Despite balloon dilatation for adequate seal, these
infoldings, which are more pronounced in the smaller
caliber iliac arteries, often persist. Although our study did
not identify a difference in the degree of oversizing as a
potential risk factor, we did not investigate the degree of
oversizing with respect to vessel diameter.
After stent deployment, our intraoperative completion
studies consisted of angiography. Although we used an-
giography in this patient population, we did not use intra-
vascular ultrasound scan. Identification of narrowed areas
allows management with balloon dilatation and stenting
(Fig 2). In addition, the degree of narrowing could be
evaluated with determination of pressure gradients, which
was not used in these patients. These attempts at identify-
ing critical stenosis allow one to correct the abnormality at
the time of surgery rather than after surgery. Unrecognized
stenosis may account for what appears to be success, only to
have the thrombosed limb identified in the early postoper-
ative period. With intravascular ultrasound scan, Amesur et
al2 reported a greater ability to identify narrowed limbs
immediately after graft placement and treat the unsup-
ported limbs with additional stenting. Although with initial
use of angiography alone the rate of limb occlusion was
17%, the institution of intravascular ultrasound scan has
improved their detection of stenosis and resulted in no
further limb thrombosis at a mean follow-up of 14
months.2
Limb thrombosis occurred within 30 days in half of the
occlusions. This is likely because of technical factors present
at the time of the procedure. Technical and judgement
errors responsible for the early postoperative limb occlu-
sions probably relate to tortuous or narrowed iliac arteries.
Most patients with limb occlusions did not undergo throm-
bolysis with subsequent angiography to help identify po-
tential sources of occlusion. In a patient who underwent
thrombolysis, a narrowed portion of the graft limb
was identified in a calcified occlusive segment of the com-
mon iliac artery. Patients with limb occlusions were more
often treated without clear identification of the likely
source and therefore underwent extraanatomic bypass. The
choice of extraanatomic bypass was made on the basis of
concern of introducing thrombus into the hypogastric cir-
culation and inability to clearly discern the source of occlu-
sion. Although any concern for femoral arteriotomy closure
site narrowing was managed with patch angioplasty, we did
not identify any correlation with the closure technique and
limb thrombosis. The delayed cases may be from the pos-
sible morphologic changes that occur in the aortoiliac
anatomy after aneurysm exclusion. Successful exclusion
results in aneurysm volume decrease as evidenced by
changes in diameter, length, and angulation.17 In their
study, as regression of the AAA occurred, limb length
varied from8 mm to10 mm, with no consistent pattern
for the change. Buckling and angulation can result from
these length changes. Studies by Umscheid and Stelter18
and Harris et al19 that investigated device conformational
changes after aneurysm repair showed patients with late
Fig 1. Endograft limb from bifurcated aortic modular graft. A, Limb with arrow indicates single longitudinal support
bar. B, Angled endograft with support bar is shown with arrow on greater curve. C, Angled endograft with support bar
on lesser curvature (arrow) resulted in endograft kinking. D, Abdominal radiograph is shown with kink (arrow) in
endograft that extended to external iliac artery. Coils are present from preoperative embolization of internal iliac.
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complications, including graft limb thrombosis, all with
distorted endografts. Comparison of postoperative angio-
grams after endovascular aneurysm repair revealed en-
dograft buckling in 69% of patients and acutely angled or
kinked endografts in 38%.19 Stent migration, separation,
and acute angulation are believed to be predisposing fac-
tors. Although early follow-up has shown unsupported
grafts are more likely to kink and thrombose,1 the conse-
quence that long-term morphologic changes in the aneu-
rysm will have on the more rigid supported19 grafts needs
to be further investigated. The need for reintervention is a
concern in the follow-up care of patients with aneurysms
treated with endovascular repair. In data from the Eurostar
registry, the need for reintervention for all indications is
estimated at an annual rate of 10%. In their review, limb
thrombosis was the most common indication for extraana-
tomic revascularization,10 a procedure that entails added
morbidity, hospitalization, and cost.
In our population of thrombosed limbs, a third of the
patients underwent management with observation for
symptoms of mild claudication. The loss of collateral flow
from the hypogastric artery, from interruption after place-
ment of the endograft to the external iliac artery, resulted in
more progressive symptoms of ischemia when thromboses
occurred.
In our series, only two thrombosed limb were managed
with endovascular means. The decision to manage the
thrombosis with extraanatomic revascularization was be-
cause of concerns that thrombectomy may have dislodged
the endograft. After thrombolysis and identification of a
narrowed graft limb, the placement of a stent within stent
reinforced endografts may produce frictional forces that
over time could result in fabric failure with subsequent
endoleak.20
CONCLUSION
Infrarenal aortic aneurysm endografting that uses small
aortic graft limb diameter and extension to the external iliac
artery predisposes to graft limb thrombosis. Most of these
patients will have symptoms that necessitate repeat inter-
vention. Successful intervention, including extraanatomic
bypass thrombolysis, angioplasty, and stenting, is successful
in reestablishing arterial perfusion and relieving ischemic
symptoms without permanent sequelae.
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